Case Study: Regeneron, Sanofi’s Dupilumab Development to approval
The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug for moderate-to-severe atopic dermatitis. Bio-molecule: Dupilumab... Read More
2017 USFDA New Drug Approval: Amgen’s Parsabiv™ (Etelcalcetide)
U.S. Food and Drug Administration (FDA) has approved Amgen’s Parsabiv™ (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with... Read More